Literature DB >> 25361845

Mutant KRAS-induced expression of ICAM-1 in pancreatic acinar cells causes attraction of macrophages to expedite the formation of precancerous lesions.

Geou-Yarh Liou1, Heike Döppler1, Brian Necela1, Brandy Edenfield1, Lizhi Zhang2, David W Dawson3, Peter Storz4.   

Abstract

UNLABELLED: Desmoplasia and an inflammatory environment are defining features of pancreatic cancer. Unclear is how pancreatic cells that undergo oncogenic transformation can cross-talk with immune cells and how this contributes to the development of pancreatic lesions. Here, we demonstrate that pancreatic acinar cells expressing mutant KRAS can expedite their transformation to a duct-like phenotype by inducing local inflammation. Specifically, we show that KRAS(G12D) induces the expression of intercellular adhesion molecule-1 (ICAM-1), which serves as chemoattractant for macrophages. Infiltrating macrophages amplify the formation of KRAS(G12D)-caused abnormal pancreatic structures by remodeling the extracellular matrix and providing cytokines such as TNF. Depletion of macrophages or treatment with a neutralizing antibody for ICAM-1 in mice expressing oncogenic Kras under an acinar cell-specific promoter resulted in both a decreased formation of abnormal structures and decreased progression of acinar-to-ductal metaplasia to pancreatic intraepithelial neoplastic lesions. SIGNIFICANCE: We here show that oncogenic KRAS in pancreatic acinar cells upregulates the expression of ICAM-1 to attract macrophages. Hence, our results reveal a direct cooperative mechanism between oncogenic Kras mutations and the inflammatory environment to drive the initiation of pancreatic cancer. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25361845      PMCID: PMC4293204          DOI: 10.1158/2159-8290.CD-14-0474

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   39.397


  50 in total

1.  Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.

Authors:  E L Jackson; N Willis; K Mercer; R T Bronson; D Crowley; R Montoya; T Jacks; D A Tuveson
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

2.  Anti-ICAM-1 monoclonal antibody R6.5 (Enlimomab) promotes activation of neutrophils in whole blood.

Authors:  J Vuorte; P J Lindsberg; M Kaste; S Meri; S E Jansson; R Rothlein; H Repo
Journal:  J Immunol       Date:  1999-02-15       Impact factor: 5.422

3.  PTEN is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-κB-cytokine network.

Authors:  Haoqiang Ying; Kutlu G Elpek; Anant Vinjamoori; Stephanie M Zimmerman; Gerald C Chu; Haiyan Yan; Eliot Fletcher-Sananikone; Hailei Zhang; Yingchun Liu; Wei Wang; Xiaojia Ren; Hongwu Zheng; Alec C Kimmelman; Ji-hye Paik; Carol Lim; Samuel R Perry; Shan Jiang; Brian Malinn; Alexei Protopopov; Simona Colla; Yonghong Xiao; Aram F Hezel; Nabeel Bardeesy; Shannon J Turley; Y Alan Wang; Lynda Chin; Sarah P Thayer; Ronald A DePinho
Journal:  Cancer Discov       Date:  2011-05-23       Impact factor: 39.397

4.  Antibody blockade of ICAM-1 and VCAM-1 ameliorates inflammation in the SAMP-1/Yit adoptive transfer model of Crohn's disease in mice.

Authors:  R C Burns; J Rivera-Nieves; C A Moskaluk; S Matsumoto; F Cominelli; K Ley
Journal:  Gastroenterology       Date:  2001-12       Impact factor: 22.682

5.  Tumor necrosis factor-alpha-converting enzyme (TACE/ADAM-17) mediates the ectodomain cleavage of intercellular adhesion molecule-1 (ICAM-1).

Authors:  Nina L Tsakadze; Srinivas D Sithu; Utpal Sen; William R English; Gillian Murphy; Stanley E D'Souza
Journal:  J Biol Chem       Date:  2005-12-06       Impact factor: 5.157

6.  Tumor-derived intercellular adhesion molecule-1 mediates tumor-associated leukocyte infiltration in orthotopic pancreatic xenografts.

Authors:  Christina L Roland; Sean P Dineen; Jason E Toombs; Juliet G Carbon; C Wayne Smith; Rolf A Brekken; Carlton C Barnett
Journal:  Exp Biol Med (Maywood)       Date:  2010-02

7.  Activated rat pancreatic stellate cells express intercellular adhesion molecule-1 (ICAM-1) in vitro.

Authors:  Atsushi Masamune; Yoshitaka Sakai; Kazuhiro Kikuta; Masahiro Satoh; Akihiko Satoh; Tooru Shimosegawa
Journal:  Pancreas       Date:  2002-07       Impact factor: 3.327

Review 8.  K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.

Authors:  R H Hruban; A D van Mansfeld; G J Offerhaus; D H van Weering; D C Allison; S N Goodman; T W Kensler; K K Bose; J L Cameron; J L Bos
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

9.  Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice.

Authors:  Carmen Guerra; Alberto J Schuhmacher; Marta Cañamero; Paul J Grippo; Lena Verdaguer; Lucía Pérez-Gallego; Pierre Dubus; Eric P Sandgren; Mariano Barbacid
Journal:  Cancer Cell       Date:  2007-03       Impact factor: 31.743

10.  Macrophage-secreted cytokines drive pancreatic acinar-to-ductal metaplasia through NF-κB and MMPs.

Authors:  Geou-Yarh Liou; Heike Döppler; Brian Necela; Murli Krishna; Howard C Crawford; Massimo Raimondo; Peter Storz
Journal:  J Cell Biol       Date:  2013-08-05       Impact factor: 10.539

View more
  78 in total

Review 1.  Emerging cytokine networks in colorectal cancer.

Authors:  Nathan R West; Sarah McCuaig; Fanny Franchini; Fiona Powrie
Journal:  Nat Rev Immunol       Date:  2015-09-11       Impact factor: 53.106

Review 2.  Protein kinase D enzymes: novel kinase targets in pancreatic cancer.

Authors:  Geou-Yarh Liou; Peter Storz
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2015-07-17       Impact factor: 3.869

Review 3.  Systems biology approach to developing S(2)RM-based "systems therapeutics" and naturally induced pluripotent stem cells.

Authors:  Greg Maguire; Peter Friedman
Journal:  World J Stem Cells       Date:  2015-05-26       Impact factor: 5.326

Review 4.  Cellular determinants and therapeutic implications of inflammation in pancreatic cancer.

Authors:  Meredith L Stone; Gregory L Beatty
Journal:  Pharmacol Ther       Date:  2019-05-31       Impact factor: 12.310

5.  Pomalidomide Alters Pancreatic Macrophage Populations to Generate an Immune-Responsive Environment at Precancerous and Cancerous Lesions.

Authors:  Ligia I Bastea; Geou-Yarh Liou; Veethika Pandey; Alicia K Fleming; Christina A von Roemeling; Heike Doeppler; Zhimin Li; Yushi Qiu; Brandy Edenfield; John A Copland; Han W Tun; Peter Storz
Journal:  Cancer Res       Date:  2019-01-29       Impact factor: 12.701

6.  Genetically Engineered Mouse Models of Pancreatic Cancer: The KPC Model (LSL-Kras(G12D/+) ;LSL-Trp53(R172H/+) ;Pdx-1-Cre), Its Variants, and Their Application in Immuno-oncology Drug Discovery.

Authors:  Jae W Lee; Chad A Komar; Fee Bengsch; Kathleen Graham; Gregory L Beatty
Journal:  Curr Protoc Pharmacol       Date:  2016-06-01

Review 7.  Macrophages: Key orchestrators of a tumor microenvironment defined by therapeutic resistance.

Authors:  Kristen B Long; Arthur I Collier; Gregory L Beatty
Journal:  Mol Immunol       Date:  2017-12-19       Impact factor: 4.407

8.  The Presence of Interleukin-13 at Pancreatic ADM/PanIN Lesions Alters Macrophage Populations and Mediates Pancreatic Tumorigenesis.

Authors:  Geou-Yarh Liou; Ligia Bastea; Alicia Fleming; Heike Döppler; Brandy H Edenfield; David W Dawson; Lizhi Zhang; Nabeel Bardeesy; Peter Storz
Journal:  Cell Rep       Date:  2017-05-16       Impact factor: 9.423

9.  KRAS mutation and epithelial-macrophage interplay in pancreatic neoplastic transformation.

Authors:  Faraz Bishehsari; Lijuan Zhang; Usman Barlass; Nailliw Z Preite; Sanja Turturro; Matthew S Najor; Brandon B Shetuni; Janet P Zayas; Mahboobeh Mahdavinia; Abde M Abukhdeir; Ali Keshavarzian
Journal:  Int J Cancer       Date:  2018-08-09       Impact factor: 7.396

10.  γδ T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell Activation.

Authors:  Donnele Daley; Constantinos Pantelis Zambirinis; Lena Seifert; Neha Akkad; Navyatha Mohan; Gregor Werba; Rocky Barilla; Alejandro Torres-Hernandez; Mautin Hundeyin; Vishnu Raj Kumar Mani; Antonina Avanzi; Daniel Tippens; Rajkishen Narayanan; Jung-Eun Jang; Elliot Newman; Venu Gopal Pillarisetty; Michael Loran Dustin; Dafna Bar-Sagi; Cristina Hajdu; George Miller
Journal:  Cell       Date:  2016-08-25       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.